Antios Therapeutics, Inc
6 clinical trials · Sponsor
◉ Watch Antios Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects (NCT05298332) | Antios Therapeutics, Inc | 2022-03-29 |
| A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects (NCT05137600) | Antios Therapeutics, Inc | 2021-10-28 |
| A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy Subjects (NCT05137548) | Antios Therapeutics, Inc | 2021-10-27 |
| A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection (NCT04847440) | Antios Therapeutics, Inc | 2021-03-30 |
| A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection (NCT04248426) | Antios Therapeutics, Inc | 2020-02-05 |
Track Antios Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.